Cargando…
Comment on ‘Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures’
Autores principales: | Schaffalitzky de Muckadell, Philip, Strom, Claes Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165130/ https://www.ncbi.nlm.nih.gov/pubmed/32253716 http://dx.doi.org/10.1007/s40264-020-00929-0 |
Ejemplares similares
-
Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures
por: Nathell, Lennart, et al.
Publicado: (2019) -
Comment on ‘Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron(III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ Between 2014 and 2017’
por: Schaffalitzky de Muckadell, Philip, et al.
Publicado: (2019) -
Hypersensitivity to Intravenous Iron Preparations
por: Caimmi, Silvia, et al.
Publicado: (2022) -
Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
por: Siderov, J, et al.
Publicado: (2002) -
Validation of a Simple Quality‐of‐Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy
por: Lauridsen, Mette Munk, et al.
Publicado: (2020)